title: Presence of Lactobacillus reuteri in saliva coincide with higher salivary IgA in young adults after intake of probiotic lozenges.
abstract: The aim of this study was to compare the concentration of salivary immunoglobulin A (IgA) and the selected interleukins (IL)-1β, IL-6, IL-8 and IL-10 in young individuals with presence and non-presence of Lactobacillus reuteri in saliva after a three-week intervention with probiotic lozenges. The study group consisted of 47 healthy individuals aged 18-32 years with no clinical signs of oral inflammation. In a randomised, double-blind, placebo-controlled, cross-over trial participants ingested two lozenges per day containing two strains of the probiotic bacterium L. reuteri or placebo lozenges. The intervention and wash-out periods were three weeks. Stimulated and unstimulated whole saliva was collected at baseline and immediately after termination of the intervention periods. The samples were analysed for total protein, salivary IgA and selected cytokines. In this extended analysis, data were collected by analysing baseline and follow-up saliva samples related to ingestion of the probiotic lozenges for the presence of L. reuteri through DNA-extraction, PCR-amplification and gel-electrophoresis. At baseline, 27% of the individuals displayed presence of L. reuteri and 42% were positive immediately after the three-week probiotic intervention. Individuals with presence of L. reuteri in saliva had significantly higher (P<0.05) concentrations of salivary IgA and %IgA/protein at the termination of the probiotic intake compared with non-presence. No differences in the cytokine levels were observed. In conclusion, detectable levels of L. reuteri in saliva coincided with higher concentrations of salivary IgA and %IgA/protein in stimulated whole saliva after the three-week daily intake of probiotic lozenges. Our findings suggest that monitoring the presence of probiotic candidates in the oral environment is important to interpret and understand their possible immune-modulating role in maintaining oral health.
authors.affiliation: 1 Department of Cariology, Faculty of Odontology, Malmö University, Carl Gustafs väg 34, 214 21 Malmö, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Braathen
authors.affiliation: 1 Department of Cariology, Faculty of Odontology, Malmö University, Carl Gustafs väg 34, 214 21 Malmö, Sweden.
authors.forename: V
authors.initials: V
authors.lastname: Ingildsen
authors.affiliation: 2 Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Nørre Allé 20, 2200 Copenhagen N, Denmark.
authors.forename: S
authors.initials: S
authors.lastname: Twetman
authors.affiliation: 1 Department of Cariology, Faculty of Odontology, Malmö University, Carl Gustafs väg 34, 214 21 Malmö, Sweden.
authors.forename: D
authors.initials: D
authors.lastname: Ericson
authors.affiliation: 2 Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Nørre Allé 20, 2200 Copenhagen N, Denmark.
authors.forename: M R
authors.initials: MR
authors.lastname: Jørgensen
mesh_terms: D000293:Adolescent; D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007378:Interleukins / Q000032:analysis; D052200:Limosilactobacillus reuteri / Q000276:immunology*; D008297:Male; D010919:Placebos; D019936:Probiotics / Q000008:administration & dosage; D012463:Saliva / Q000276:immunology / Q000382:microbiology*; D013607:Tablets / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D007070:Immunoglobulin A; D007378:Interleukins; D010919:Placebos; D013607:Tablets
keywords: cytokine; immunoglobulin; immunology; lactobacilli